myelodysplastic syndromes event in both ''atypical'' myeloproliferative disorders and The JAK2 V617F activating tyrosine kinase mutation is an infrequent
暂无分享,去创建一个
R. Levine | D. Gilliland | D. Steensma | H. Powell | A. Tefferi | G. Dewald | T. Lasho | R. McClure | R. Mcclure